Loading clinical trials...
Loading clinical trials...
Determination of Ustekinumab Levels in Patients With Crohn's Disease: Use in Clinical Practice
Observational, prospective, single-center follow-up study carried out with patients from the area of the Virgen de Macarena University Hospital, diagnosed with chronic kidney disease, who started treatment with ustekinumab.
Prospective follow-up observational study carried out with patients from the Virgen de Macarena University Hospital, under treatment with ustekinumab in the induction and maintenance phase in order to determine the cut-off points of the ustekinumab levels between which a clinical remission is expected in patients with inflammatory bowel disease.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Hospital Universitario Virgen de Macarena
Seville, Spain
Start Date
May 1, 2021
Primary Completion Date
February 1, 2022
Completion Date
February 1, 2022
Last Updated
November 17, 2021
95
ESTIMATED participants
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
NCT07245394
NCT07089420
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions